Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Post date: 2025-05-03 01:48:48
Views: 1
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.